DELUCIA DAVID (Chief Financial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0002040705-25-000002
Officer· Chief Financial Officer
Since Mar 2026
-52.00
Net shares
Net seller
$437.84
Total sold
0
Open market trades
0B · 0S
1
Total transactions
52.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−52.00
Price / share
$8.42
Trade value
$437.84
% of position
1.1%
12/6/2025
4.54K→4.49K
Total
Net shares
−52.00
Net value
-$437.84
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2025 | F · Tax Withholding | −52.00 | $8.42 | $437.84 | 1.1% | 4.54K | 4.49K |
| Total | −52.00 | -$437.84 | ||||||
Derivative Transactions0
No derivative transactions reported